{"id":147229,"date":"2023-05-24T08:28:44","date_gmt":"2023-05-24T12:28:44","guid":{"rendered":"https:\/\/44.250.171.167\/?p=147229"},"modified":"2023-05-24T08:28:46","modified_gmt":"2023-05-24T12:28:46","slug":"alphagraph-biocon-limited-nse-biocon-q4fy23-results-out-total-income-rises-58-yoy","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/alphagraph-biocon-limited-nse-biocon-q4fy23-results-out-total-income-rises-58-yoy\/","title":{"rendered":"Alphagraph | Biocon Limited (NSE: BIOCON): Q4FY23 Results Out; Total Income rises 58% YoY."},"content":{"rendered":"\n

Biocon is a prominent player in the biotechnology industry, specializing in the manufacturing of biotechnology products and offering research services. With a strong focus on innovation and scientific expertise, Biocon has made significant contributions to the field of biotechnology. The company’s diverse portfolio encompasses a range of biopharmaceuticals, including biosimilars, novel biologics, and small molecules. Through its cutting-edge research and development efforts, Biocon continues to pioneer advancements in the healthcare sector, providing high-quality and affordable solutions to address critical medical needs. With its commitment to improving patient outcomes and advancing healthcare globally, Biocon remains at the forefront of the biotechnology landscape.<\/p>\n\n\n\n

\"\"<\/figure>\n","protected":false},"excerpt":{"rendered":"

Biocon is a prominent player in the biotechnology industry, specializing in the manufacturing of biotechnology products and offering research services. With a strong focus on innovation and scientific expertise, Biocon has made significant contributions to the field of biotechnology. The company’s diverse portfolio encompasses a range of biopharmaceuticals, including biosimilars, novel biologics, and small molecules. […]<\/p>\n","protected":false},"author":1932,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[392],"tags":[1115],"class_list":["post-147229","post","type-post","status-publish","format-standard","hentry","category-earnings","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":172340,"url":"https:\/\/alphastreet.com\/india\/biocon-q2-fy26-earnings-results\/","url_meta":{"origin":147229,"position":0},"title":"Biocon Q2 FY26 Earnings Results","author":"Divyansh_Kasana","date":"November 12, 2025","format":false,"excerpt":"Biocon Ltd, a prominent biotechnology company engaged in manufacturing biotechnology products and research services, reported extraordinary financial results for Q2FY26. Financial Highlights: Revenues grew 19.67% year-on-year to \u20b94,296 crore from \u20b93,590 crore. Total expenses increased 18.42% to \u20b94,205 crore from \u20b93,551 crore. Consolidated net profit skyrocketed 392.59% to \u20b9133 crore\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Q2 FY26","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/BIO.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/BIO.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/BIO.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/BIO.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/BIO.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/BIO.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":165678,"url":"https:\/\/alphastreet.com\/india\/biocon-ltd-q2fy25-84-fall-in-profits\/","url_meta":{"origin":147229,"position":1},"title":"Biocon Ltd Q2FY25; 84% fall in Profits","author":"Divyansh_Kasana","date":"November 18, 2024","format":false,"excerpt":"Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195) Financial Results: Biocon Ltd reported Revenues for Q2FY25 of \u20b93,590.00 Crores up from \u20b93,462.00 Crore year on year, a rise of 3.7%. Total Expenses for Q2FY25 of \u20b93,551.00 Crores up\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DI.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DI.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DI.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DI.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DI.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DI.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":168500,"url":"https:\/\/alphastreet.com\/india\/biocon-ltd-q4fy25-106-rise-in-profits\/","url_meta":{"origin":147229,"position":2},"title":"Biocon Ltd Q4FY25; 106% rise in Profits","author":"Divyansh_Kasana","date":"May 27, 2025","format":false,"excerpt":"Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195) Financial Results: Biocon Ltd reported Revenues for Q4FY25 of \u20b94,417.00 Crores up from \u20b93,917.00 Crore year on year, a rise of 12.76%. Total Expenses for Q4FY25 of \u20b93,987.00 Crores up\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/L-12.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/L-12.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/L-12.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/L-12.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/L-12.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/L-12.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167293,"url":"https:\/\/alphastreet.com\/india\/biocon-ltd-q3fy25-89-fall-in-profits\/","url_meta":{"origin":147229,"position":3},"title":"Biocon Ltd Q3FY25; 89% fall in Profits","author":"Divyansh_Kasana","date":"March 10, 2025","format":false,"excerpt":"Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195) Financial Results: Biocon Ltd reported Revenues for Q3FY25 of \u20b93,821.00 Crores down from \u20b93,954.00 Crore year on year, a fall of 3.36%. Total Expenses for Q3FY25 of \u20b93,718.00 Crores down\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/J-2.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/J-2.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/J-2.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/J-2.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/J-2.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/J-2.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":170318,"url":"https:\/\/alphastreet.com\/india\/biocon-q1-fy26-earnings-results\/","url_meta":{"origin":147229,"position":4},"title":"Biocon Q1 FY26 Earnings Results","author":"Divyansh_Kasana","date":"August 19, 2025","format":false,"excerpt":"Biocon Limited, engaged in the manufacture of biotechnology products and research services, reported its Q1 FY26 Earnings results. Q1 FY26 Earnings Results Revenue: \u20b93,942 crore, up 14.83% year-on-year (YoY) from \u20b93,433 crore in Q1 FY25. Total Expenses: \u20b93,925 crore, up 13.67% YoY from \u20b93,453 crore. Consolidated Net Profit (PAT): \u20b989\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"BIOCON Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/BIOCON.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/BIOCON.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/BIOCON.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/BIOCON.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/BIOCON.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/BIOCON.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":157327,"url":"https:\/\/alphastreet.com\/india\/biocon-ltd-q2fy24-111-rise-in-profits\/","url_meta":{"origin":147229,"position":5},"title":"Biocon Ltd Q2FY24; 111% rise in Profits","author":"Divyansh_Kasana","date":"December 14, 2023","format":false,"excerpt":"Biocon is engaged in the business of manufacture of biotechnology products and research services. Financial Results: Biocon Ltd reported Revenues for Q2FY24 of \u20b93,462.00 Crores up from \u20b92,320.00 Crore year on year, a rise of 49.22%. Total Expenses for Q2FY24 of \u20b93,382.00 Crores up from \u20b92,138.00 Crores year on year,\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-106.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-106.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-106.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-106.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-106.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-106.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/147229","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=147229"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/147229\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=147229"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=147229"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=147229"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}